The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0
|
作者：
Constance Delaby
Teresa Estellés
Nuole Zhu
Javier Arranz
Isabel Barroeta
María Carmona-Iragui
Ignacio Illán-Gala
Miguel Ángel Santos-Santos
Miren Altuna
Isabel Sala
M. Belén Sánchez-Saudinós
Laura Videla
Sílvia Valldeneu
Andrea Subirana
Mireia Tondo
Francisco Blanco-Vaca
Sylvain Lehmann
Olivia Belbin
Rafael Blesa
Juan Fortea
Alberto Lleó
Daniel Alcolea
机构：
[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology
[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular
[3] IRMB,undefined
[4] INM,undefined
[5] Université de Montpellier,undefined
[6] INSERM,undefined
[7] CHU de Montpellier,undefined
[8] Laboratoire de Biochimie-Protéomique clinique,undefined
[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined
[10] CIBERNED,undefined
[11] Fundació Catalana Síndrome de Down,undefined
[12] Centre Mèdic Down,undefined
[13] Servei de Bioquímica,undefined
[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined
[15] Universitat Autònoma de Barcelona,undefined
[16] Unversitat Autònoma de Barcelona,undefined
[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Recombinant Amyloid-β Peptide Aβ1-42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1-42
    Finder, Verena H.
    Vodopivec, Ivana
    Nitsch, Roger M.
    Glockshuber, Rudi
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 396 (01) : 9 - 18
  • [22] Total-tau, Aβ1-42 and Ubiquitin in CSF in the diagnosis of Alzheimer disease
    Iqbal, K
    EUROPEAN PSYCHIATRY, 2002, 17 : 76S - 76S
  • [23] Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
    Baiardi, Simone
    Abu-Rumeileh, Samir
    Rossi, Marcello
    Zenesini, Corrado
    Bartoletti-Stella, Anna
    Polischi, Barbara
    Capellari, Sabina
    Parchi, Piero
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 263 - 273
  • [24] Plasma p-tau181/A beta(1-42) ratio predicts A beta-PET status and correlates with CSF-p-tau181/A beta(1-42) and future cognitive decline
    Fowler, Christopher J.
    Stoops, Erik
    Rainey-Smith, Stephanie R.
    Vanmechelen, Eugeen
    Vanbrabant, Jeroen
    Dewit, Nele
    Mauroo, Kimberley
    Maruff, Paul
    Rowe, Christopher C.
    Fripp, Jurgen
    Li, Qiao-Xin
    Bourgeat, Pierrick
    Collins, Steven J.
    Martins, Ralph N.
    Masters, Colin L.
    Doecke, James D.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
  • [25] CSF Aβ1–42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer’s Disease Dementia
    Liara Rizzi
    Luciane Missiaggia
    Matheus Roriz-Cruz
    NeuroMolecular Medicine, 2018, 20 : 491 - 497
  • [26] Why is the C-terminus of Aβ(1-42) more unfolded than that of Aβ(1-40)?: Clues from hydrophobic interaction
    Shen, Liang
    Ji, Hong-Fang
    Zhang, Hong-Yu
    JOURNAL OF PHYSICAL CHEMISTRY B, 2008, 112 (10): : 3164 - 3167
  • [27] Effects of processing and storage conditions on CSF amyloid β (1-42) and tau concentrations:: Implications for use in clinical practice
    Blankenstein, MA
    Schoonenboom, NSM
    Mulder, C
    Vanderstichele, H
    van Elk, EJ
    Kok, A
    Van Kamp, GJ
    Scheltens, P
    CLINICA CHIMICA ACTA, 2005, 355 : S217 - S217
  • [28] Study of plasma levels of Aβ1-42, Aβ1-40, and p-tau in Alzheimer disease
    Peng, D
    Cai, X
    Xu, X
    Wang, X
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (04): : 614 - 615
  • [29] Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF
    Hulstaert, F
    Blennow, K
    Ivanoiu, A
    Schoonderwaldt, HC
    Riemenschneider, M
    De Deyn, PP
    Bancher, C
    Cras, P
    Wiltfang, J
    Mehta, PD
    Iqbal, K
    Pottel, H
    Vanmechelen, E
    Vanderstichele, H
    NEUROLOGY, 1999, 52 (08) : 1555 - 1562
  • [30] CSF Aβ1-42, but not p-Tau181, differentiates aMCI from SCI
    Rizzi, Liara
    Portal, Marcelle Maria
    Alves Batista, Carlos Eduardo
    Missiaggia, Luciane
    Roriz-Cruz, Matheus
    BRAIN RESEARCH, 2018, 1678 : 27 - 31
12345